. 2019 Aug 10;11(8):1859. doi: 10.3390/nu11081859

Table 4.

Relative abundance of major genera within the fecal microbiota.

Genus	Treatment	Composition of Bacterial Genus (%) *
		Baseline	24 Weeks	Change
Bifidobacterium ^†	CP2305	9.8 ± 1.8	6.1 ± 1.3	−3.6 ± 1.2
Bifidobacterium ^†	Placebo	14.7 ± 2.6	6.8 ± 1.3	−7.9 ± 2.3
Faecalibacterium	CP2305	10.5 ± 1.8	16.5 ± 2.0	6.0 ± 1.4
Faecalibacterium	Placebo	6.8 ± 1.0	12.4 ± 1.9	5.6 ± 1.7
Roseburia	CP2305	4.5 ± 1.2	4.7 ± 1.0	0.2 ± 1.2
Roseburia	Placebo	2.8 ± 0.6	6.6 ± 1.5	3.7 ± 1.4
Streptococcus ^†	CP2305	1.8 ± 0.7	1.6 ± 0.6	−0.2 ± 0.3
Streptococcus ^†	Placebo	1.3 ± 0.4	1.8 ± 0.5	0.5 ± 0.6
Dorea	CP2305	1.5 ± 0.2	1.8 ± 0.3	0.3 ± 0.3
Dorea	Placebo	1.7 ± 0.2	1.9 ± 0.4	0.2 ± 0.4
Lachnospiraceae; Other ^†	CP2305	2.1 ± 0.4	1.6 ± 0.3	−0.5 ± 0.2
Lachnospiraceae; Other ^†	Placebo	1.4 ± 0.3	1.4 ± 0.2	0.0 ± 0.2
Ruminococcus	CP2305	1.7 ± 0.4	2.9 ± 0.6	1.2 ± 0.7
Ruminococcus	Placebo	1.2 ± 0.3	2.8 ± 0.8	1.6 ± 0.8

* Data are presented as the mean ± SEM. ^† Significant differences between CP2305 and placebo groups (p < 0.05) by ANCOVA with each initial value as a covariate. Partial eta squared values of Bifidobacterium, Streptococcus, and Lachnospiraceae; Other are 0.096, 0.152, and 0.158, respectively.